SHANGHAI: German life sciences company Bayer AG is confident about the rapidly developing Chinese pharmaceutical market and will continue to invest and bring more innovative products into the country, the head of its pharmaceuticals division says.
“China has been and remains one of our most important markets. It is developing fast and its healthcare system is becoming much more similar to what I am used to in Europe.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
